Liraglutide (TFA) is an agonist of glucagon-like peptide 1 receptor (GLP-1). Liraglutide (TFA) can activate GLP-1, leading to the release of insulin in the presence of increased glucose concentration. Liraglutide (TFA) also reduces glucagon secretion in a glucose-dependent manner. Liraglutide (TFA) can be studied in research on type 2 diabetes[1].
Molecular Weight:
3751.20 (free base)
Purity:
99.56
Formula:
C172H265N43O51.xC2HF3O2
Target:
GLP Receptor
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
